Business
Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia
Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia.
About this update from Bioelectronics Corp.
[{"type":"text","content":"\n\n\n\nPifflers United - \"Supporting Anyone Living With Chronic/Invisible Illness\" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPifflers United - \"Supporting Anyone Living With Chronic/Invisible Illness\" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia\nPR Newswire\nDEVON, England, Nov. 24, 2014\n\n\n\nDEVON, England, Nov. 24, 2014 /PRNewswire/ -- Pifflers United Chronic and Invisible Illnesses Support Community, https://www.facebook.com/PifflersUnited announced the release of results of a study of ActiPatch®, a new bioelectronic pain therapy device, in the self-management of fibromyalgia pain. The results demonstrated that when used in the area of worst pain, very significant clinically meaningful pain reduction can be achieved. \n\nThe 140 group members with fibromyalgia used ActiPatch® for 7 days and were then sent a survey questionnaire to assess their experience; 74 members of the group completed the questionnaire. The average pain reduction across all the respondents was 33% with 79% of them reporting a pain decrease. When analyzed excluding those with no or very little pain improvement, the therapeutic response rate was 69% with a 47% reduction in pain.\n\n\"These findings are remarkable in a notoriously difficult to treat condition and will be welcomed by the fibromyalgia population and chronic pain community who, as a consequence of ineffective or insufficient pain therapy, often suffer from very high baseline pain levels. This is an opportunity for fibromyalgics to self-manage their pain using a therapy that is safe, effective, affordable and easy to use,\" says Tracy Thorogood, Pifflers ' Founder. \"ActiPatch® Therapy offers an invaluable new over the counter treatment that helps improve quality of life.\" \n\nTracy Thorogood said \"I suffer from the chronic condition that is Fibromyalgia and set up a social network group to support other chronic illness sufferers late last year.  Earlier this year, I was introduced to Act...